BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32989212)

  • 21. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
    Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
    Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA LINC00467 contributes to osteosarcoma growth and metastasis through regulating HMGA1 by directly targeting miR-217.
    Ma HZ; Wang J; Shi J; Zhang W; Zhou DS
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5933-5945. PubMed ID: 32572906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
    Zhang Y; Li KF
    Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
    Cao XP; Cao Y; Zhao H; Yin J; Hou P
    Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
    Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.
    Resar L; Chia L; Xian L
    Cancer Res; 2018 Apr; 78(8):1890-1897. PubMed ID: 29618461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma.
    Toyozumi T; Hoshino I; Takahashi M; Usui A; Akutsu Y; Hanari N; Murakami K; Kano M; Akanuma N; Suitoh H; Matsumoto Y; Sekino N; Komatsu A; Matsubara H
    Ann Surg Oncol; 2017 Oct; 24(11):3446-3455. PubMed ID: 27882471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
    Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
    Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between HMGA1 and immunosuppression in hepatocellular carcinoma: A comprehensive bioinformatics analysis.
    Zhu J; Zheng Y; Liu Y; Chen M; Liu Y; Li J
    Medicine (Baltimore); 2023 Jan; 102(4):e32707. PubMed ID: 36705364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.
    Goos JA; Coupe VM; Diosdado B; Delis-Van Diemen PM; Karga C; Beliën JA; Carvalho B; van den Tol MP; Verheul HM; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
    Br J Cancer; 2013 Oct; 109(9):2445-52. PubMed ID: 24104968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
    Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
    Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
    Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
    Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
    Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer.
    Hu Y; Dai M; Zheng Y; Wu J; Yu B; Zhang H; Kong W; Wu H; Yu X
    Clin Epigenetics; 2018 Dec; 10(1):154. PubMed ID: 30541610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
    Méndez O; Peg V; Salvans C; Pujals M; Fernández Y; Abasolo I; Pérez J; Matres A; Valeri M; Gregori J; Villarreal L; Schwartz S; Ramon Y Cajal S; Tabernero J; Cortés J; Arribas J; Villanueva J
    Clin Cancer Res; 2018 Dec; 24(24):6367-6382. PubMed ID: 30135148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.
    Nambara S; Masuda T; Kobayashi Y; Sato K; Tobo T; Koike K; Noda M; Ogawa Y; Kuroda Y; Ito S; Eguchi H; Sugimachi K; Mimori K
    Cancer Sci; 2020 Feb; 111(2):343-355. PubMed ID: 31758608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
    Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
    Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
    Wang CQ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3771-3778. PubMed ID: 31115003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.